MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Breast Cancer · Gastrointestinal Cancer · Lung Cancer (Diagnosis) · Prostate Cancer (Diagnosis) · Head and Neck Cancer (H&N) · Bladder Cancer
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - 70 years
- Sex eligible
- All sexes
- Healthy volunteers
- Accepted
- Participants
- 100 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
Read the full description
This study focuses on testing the effectiveness of MyPatientPal+, the combination of MyPatientPal smartphone app and a newly developed provider dashboard, on patient quality of life, adherence to medications, and severity of side effects on patients who are on cancer treatment. Participants will use the MyPatientPal+ smartphone daily to complete daily patient reported outcome questions (PROs) for 8 weeks. Providers will enter information as desired and not on a set schedule.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
Patients-
- 18-70 Years of age
- have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer
- about to initiate chemotherapy using one of the regimens listed in the protocol
- be able to speak, read, and write English
- willing and able to provide consent
- have access to a stable internet connection
Providers:
- being a practicing oncologist
- treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app
- provide consent for the study
Exclusion Criteria:
Patients-
- cognitive or perceptual disturbances that prevent completing study measures Provider-
- None
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Not applicable
- Masking
- No masking
MyPatientPal+ Smartphone Application
Participants report daily side effects and medications. Application includes a provider dashboard to track patients side effects and medications.
Behavioral: MyPatientPal+
MyPatientPal+ BEHAVIORAL
The intervention will consist of patients using the MyPatientPal+ application to complete daily patient reported outcome questions (PROs) of: (a) patient quality of life, (b) medication use, and (c) severity of side effects, and their providers who will elect to receive a weekly summary of patient's daily PRO reports electronically (e.g., email) or through the dashboard.
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Single-item daily Quality of Life (Patient)
Time frame: Daily for 8 weeks
Patients will report their daily quality of life daily using MyPatientPal smartphone app. The question: "How was your quality of life today?" has a 7-point scale ranging from 1=very poor to 7=excellent.
Secondary measures
Adherence to medications (patient)
Time frame: Daily for 8 weeks
Patients will report any medications they are taking related to their treatment. Each report will consist of them answering a forced-choice question about whether each of their prescribed medications was taken (0=yes, 1=no). The investigators will compare the ratio of total days of adherence/total number of days per medication between the weekly and daily reporting phases. There will be no set number of medications that will be assessed given that the app will be set up to record only those medications the patient is prescribed, but on average, most patients will report on 3 medications. Examples may include Xeloda, Ibrance, Femara, Tamoxifen, Remeron, Reglan, or Compazine.
Severity of side effects (patient)
Time frame: Daily for 8 weeks
The severity of treatment-related symptoms will be examined as the primary outcome. Patients will report the severity of symptoms selected to match their current or expected side using the National Cancer Institute (NCI) CTCAE (Common Terminology Criteria for Adverse Events). Examples include diarrhea, constipation, vomiting, fever, and fatigue. Patients will be asked to mark the severity of each symptom using a 5-point rating scale (from 0=none to 4=very severe).
Patient quality of life
Time frame: Weekly for 8 weeks
Patients will report their quality of life using the FACT-G (Functional Assessment of Cancer Therapy), a widely accepted measure of general functioning and quality of life among cancer patients. The measure has a total score and also four subscales assessing social, functional, emotional, and physical domains.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
Karmanos Cancer InstituteDetroit, Michigan, United StatesStatus unknown
Study team and timeline
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Study start
- 2026-11 Estimated
- Primary completion
- Nov 30, 2028 Estimated
- Study completion
- Nov 30, 2028 Estimated
- First posted
- Nov 10, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026